Japanese researchers are soon embarking on human clinical trials for a medicine that will help regrow teeth.
Related Posts
Data-integrity woes have come back to haunt Indian pharma. How can it deal with the USFDA’s glare?
Regulatory lapses have been hurting the industry since long. In several instances earlier, such issues had eroded the financials of…
Fixing India’s broken healthcare infra at the bottom, Ujala Cygnus is a rare example
India’s smaller cities and hinterland remain a neglected lot even as five-star specialty hospitals flourish in the metros. To have…
Once dumped by investors, Orchid Pharma blooms in glory with first novel antibiotic drug
Getty Images Synopsis Orchid Pharma had outlicensed its experimental antibiotic drug to Allecra Therapeutics of Germany. After years of research…